| Literature DB >> 34938843 |
Xin Zhao1,2, Lei Wang1,2, Joseph H R Maes3.
Abstract
Methamphetamine use is associated with cognitive impairments, including executive functioning. These impairments might be cause and/or effect of the drug (re-)use and have, therefore, motivated interventions to improve cognitive functioning. Until now, only very few studies have examined the effect of training working memory updating (WMU), one of the core executive functions, in this population. In the present study, 32 long-term male abstinent methamphetamine inpatients received either a multiple-session WMU training or an active control treatment. All participants performed a number of tasks assessing WMU, inhibition, and task-switching ability- before and after treatment. The WMU-trained patients improved their performance on the trained task and on a non-trained WMU task, reflecting near transfer. However, there was no beneficial training-induced effect for the other tasks, indicating the absence of far transfer. Possible treatment implications of these findings were discussed.Entities:
Keywords: Methamphetamine addiction; Training; Transfer effect; Working memory updating
Year: 2021 PMID: 34938843 PMCID: PMC8664865 DOI: 10.1016/j.abrep.2021.100385
Source DB: PubMed Journal: Addict Behav Rep ISSN: 2352-8532
Characteristics of control and trained groups.
| CTRL | TRAIN | ||
|---|---|---|---|
| N | 16 | 16 | |
| Age | 41.1 (3.1) | 39.4 (2.7) | 0.11 |
| Years of heroin use | 20.7 (2.9) | 19.8 (3.5) | 0.45 |
| Months of abstinence | 6.2 (0.8) | 6.1 (0.8) | 0.83 |
Note: Values represent means (±standard deviations). CTRL = control group; TRAIN = trained group. *p-value associated with t-test examining between-group difference.
Fig. 1Mean (+standard error of the mean) n-back level reached by the patients on each of the 20 training sessions.
Score on pre- and post-treatment test measures for the trained and control groups, and results of traditional and Bayesian ANCOVAs.
| Task/Measure | TRAIN | CTRL | ANCOVA | ANCOVA | ||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | BF10 | ||
| Stroop-RT diff | 29.42 (70.48) | 16.30 (44.02) | 30.55 (46.86) | 21.65 (28.51) | 0.17, 0.69, 0.01 | 0.34 |
| Flanker-RT diff | 39.12 (34.99) | 15.97 (9.94) | 25.23 (23.23) | 25.39 (41.55) | 1.17, 0.29, 0.04 | 0.51 |
| GNG-H-FA | 0.87 (0.08) | 0.92 (0.05) | 0.93 (0.05) | 0.95 (0.03) | 1.63, 0.21, 0.05 | 0.76 |
| Switching-RT-SC | 151.96 (179.31) | 125.91 (129.91) | 179.96 (188.78) | 152.55 (155.96) | 0.29, 0.59, 0.01 | 0.39 |
| Switching-RT-MC | 112.28 (127.89) | 90.06 (90.53) | 110.36 (150.64) | 45.83 (104.96) | 1.62, 0.21, 0.05 | 0.63 |
| RMT | 0.83 (0.13) | 0.94 (0.06) | 0.85 (0.14) | 0.82 (0.17) | 13.96, | |
Note. Values represent means (and SDs). Pre and Post = pre- and post-treatment assessment. RT diff = difference between mean RT on incongruent and congruent trials. GNG-H-FA = difference between percentage hits and false alarms for the go/no-go task. Switching-RT-SC = RT-based switch cost for the switching task. RT-MC = RT-based mixing cost for the switching task. RMT = proportion correct responses during the running memory tasks. p values in bold are significant at α = 05. Bayesian factor (BF10) in bold corresponds to strong evidence for H1.